In contrast, Novo Nordisk’s actions do not fit into the additional domains added in the OLMA framework (a recent revision of OLI), notably the mode of entry choice and adjustment factors.
Þeir viðbótarþættir sem felast í OLMA módelinu, þ.e. mode of entry og adjustment eru ekki nýttir af Novo Nordisk.